SL gets US $ 150mn ADB loan for COVID-19 vaccine drive

• Funds to be utilised to procure vaccines and other related consumables
• Contributes to government target of reaching 80% vaccine coverage by 2023 

The Asian Development Bank (ADB) and Government of Sri Lanka yesterday signed loan agreements for US $ 150 million under the Asia Pacific Vaccine Access Facility (APVAX) for the procurement of vaccines and other related consumables. 

The loan is part of ADB’s US $ 9 billion APVAX launched in December 2020 to offer rapid and equitable vaccine-related support to ADB developing member countries. 

Treasury and Finance Ministry Secretary S.R. Attygalle signed the loan agreement for the Government of Sri Lanka and ADB Country Director for Sri Lanka Chen Chen signed on behalf of ADB. 

“ADB is committed towards curtailing this pandemic and minimising its negative socioeconomic and health effects,” said Chen. 

“We are in constant contact with the government and development partners to support the country in its recovery from the pandemic.”

The loan will help finance the purchase of safe and effective coronavirus disease (COVID-19) vaccines, contributing to the government’s target to reach 80 percent vaccine coverage by 2023. 

This intervention, which targets the entire country across all 26 health districts in all nine provinces, will ensure that the geographically, socially and economically deprived populations are protected from COVID-19 and its effects. 
“ADB has been a committed partner, providing assistance where it is needed most,” said Attygalle. 

“This intervention will certainly boost the country’s vaccination drive and assist in enhancing essential infrastructure and systems in the health sector.” 

The loan aims to help strengthen the vaccination monitoring systems, vaccine transport and vaccine-related medical waste management towards enhancing the resilience and responsiveness of the health system to curtail the COVID-19 spread in the country.